Philippe Polleux

Title: Innovations of Philippe Polleux

Introduction

Philippe Polleux is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of NEP inhibitors. With a total of 4 patents to his name, his work has had a considerable impact on medical research and drug development.

Latest Patents

Philippe Polleux's latest patents focus on the synthesis of intermediates for producing NEP inhibitors or prodrugs thereof. The inventions relate to a new process for producing these inhibitors, specifically those comprising a γ-amino-δ-biphenyl-α-methylalkanoic acid or acid ester backbone. The processes are designed to synthesize intermediates that prepare NEP inhibitors, which include compounds where R1 and R2 can be hydrogen or a nitrogen protecting group, and R3 is a carboxyl group or an ester group, preferably a carboxyl group or alkyl ester.

Career Highlights

Throughout his career, Philippe Polleux has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharmaceuticals Corporation. His experience in these organizations has allowed him to collaborate on various innovative projects that advance medical science.

Collaborations

Philippe has collaborated with notable professionals in his field, including David Hook and Daniel Kaufmann. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Philippe Polleux is a distinguished inventor whose work in NEP inhibitors has paved the way for advancements in pharmaceutical research. His contributions continue to influence the industry and improve therapeutic options for patients.